Literature DB >> 27175159

Clinico-pathological findings of Clostridium perfringens type D enterotoxaemia in goats and its hemolytic activity in different erythrocytes.

A Ali Nasir1, M Younus2, A Rashid1, S Abdul Khaliq1, E Khan2, S H Shah1, A Aslam3, M A Ghumman1, M H Joiya1.   

Abstract

The present investigation was conducted to study the effects of experimental Clostridium perfringens type D enterotoxaemia in teddy goats. Clinical signs started to appear after 30 min of experimental infection like anorexia, diarrhea, dehydration, frothing and dyspnea. Gross lesions consisted of severe congestion in tissues of varying intensity with enlarged mesenteric lymph nodes while histological examination revealed edema of lungs, kidney, and lymph nodes and to some extent in brain along with hemorrhages in lungs and intestines. Clostridium perfringens type D carrying alpha and epsilon toxin genes were amplified with amplicon size about 247 bp and 665 bp, respectively. Human erythrocytes showed the highest hemolysis, 68%, followed by mice, 57%, against culture supernatants. The percentage of hemolysis was significantly higher at 37°C as compared to 25°C except for rabbit and dog.

Entities:  

Keywords:  Alpha and Epsilon genes; Clostridium perfringens type D; Enterotoxaemia ELISA; Hemolysis

Year:  2015        PMID: 27175159      PMCID: PMC4789248     

Source DB:  PubMed          Journal:  Iran J Vet Res        ISSN: 2252-0589            Impact factor:   1.376


  14 in total

1.  Partial characterization of the hemolysin produced by Clostridium chauvoei.

Authors:  Y Tamura; M Kijima; K Hamamoto; H Yoshimura
Journal:  J Vet Med Sci       Date:  1992-08       Impact factor: 1.267

Review 2.  Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D epsilon toxin: a review.

Authors:  J W Finnie
Journal:  Aust Vet J       Date:  2003-04       Impact factor: 1.281

Review 3.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system.

Authors:  O Miyamoto; J Minami; T Toyoshima; T Nakamura; T Masada; S Nagao; T Negi; T Itano; A Okabe
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells.

Authors:  M Bunting; D E Lorant; A E Bryant; G A Zimmerman; T M McIntyre; D L Stevens; S M Prescott
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

6.  Detection of Clostridium perfringens alpha toxin using a capture antibody ELISA.

Authors:  M L Hale; B G Stiles
Journal:  Toxicon       Date:  1999-03       Impact factor: 3.033

7.  Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus.

Authors:  O Miyamoto; K Sumitani; T Nakamura; S Yamagami; S Miyata; T Itano; T Negi; A Okabe
Journal:  FEMS Microbiol Lett       Date:  2000-08-01       Impact factor: 2.742

8.  Clostridium perfringens toxin-types in lambs and kids affected with gastroenteric pathologies in Italy.

Authors:  Grazia Greco; Anna Madio; Domenico Buonavoglia; Marta Totaro; Marialaura Corrente; Vito Martella; Canio Buonavoglia
Journal:  Vet J       Date:  2005-11       Impact factor: 2.688

9.  The role of clostridial toxins in the pathogenesis of gas gangrene.

Authors:  Dennis L Stevens; Amy E Bryant
Journal:  Clin Infect Dis       Date:  2002-09-01       Impact factor: 9.079

10.  Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates.

Authors:  Sameera Sayeed; Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

View more
  1 in total

1.  Chemotactic factor inducing Interleukin-8 (IL8) gene is transcriptionally elevated in experimental enterotoxaemia in goats caused by Clostridium perfringens type D.

Authors:  N K Gangwar; R V S Pawaiya; K Gururaj; D D Singh; D Andani; A Kumar; D K Sharma; A R Rao; A Rai
Journal:  Heliyon       Date:  2021-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.